Biotech

All Articles

Daiichi spends Merck $170M to create bronchi cancer T-cell engager treaty

.Merck &amp Co. has actually rapidly gotten back a number of the costs of its Harpoon Therapeutics p...

BioMarin stops preclinical genetics treatment for heart condition

.After BioMarin carried out a spring well-maintained of its own pipe in April, the business has dete...

Eisai vegetations molecular glue SEED with $1.5 B biobucks deal

.Major Pharmas stay stuck to the suggestion of molecular glue degraders. The latest business to obse...

Life scientific research credit score company unveils along with $600M

.A brand-new global lifestyle science credit rating firm, termed Symbiotic Funding, has increased mu...

BMS channels TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another major wager from the Caforio period, terminating a p...

Nuvation stops wager inhibitor after thinking about stage 1 information

.After looking at stage 1 data, Nuvation Bio has actually made a decision to stop focus on its own s...

' Clinical intuition' led FDA consultants to back Zevra's rare disease med

.Zevra Therapeutics' uncommon disease drug appears to become on the pathway to confirmation this los...

Pfizer takes $230M struck after axing failed DMD genetics therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has blown a $230 million ...

AC Immune finds 'spots' potential in Alzheimer's drug data

.After more than twenty years of deal with neurodegenerative health conditions, Swiss biotech air co...

GSK drops ph. 2 HPV vaccination over shortage of best-in-class prospective

.GSK has actually junked a period 2 human papillomavirus (HPV) injection from its own pipeline after...